S. Shankar

发表

Health Care Utilization by Adult Long-term Survivors of Hematopoietic Cell Transplant: Report from the Bone Marrow Transplant Survivor Study

L. Robison, S. Bhatia, J. Gurney, 2007, Cancer Epidemiology Biomarkers & Prevention.

the Minneapolis-Manchester Quality of Life-Youth Form Health-Related Quality of Life in Young Survivors of Childhood Cancer Using

R. Kane, L. Robison, S. Bhatia, 2013 .

R. Kane, L. Robison, S. Bhatia, 2005, Pediatrics.

Late effects of cancer treatment and quality of life

S. Bhatia, S. Shankar, 2010 .

Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine.

W. Schaffner, T. Talbot, P. Arbogast, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Amanda R. Campbell, F. Lund-Johansen, Yair Benita, 2016 .

Monitoring for Cardiovascular Disease in Survivors of Childhood Cancer: Report From the Cardiovascular Disease Task Force of the Children's Oncology Group

J. Steinberger, M. Hudson, S. Bhatia, 2008, Pediatrics.

Medical care utilization and mortality in sickle cell disease: A population‐based study

P. Arbogast, Winfred C. Wang, W. Cooper, 2005, American journal of hematology.

Longitudinal differences in aerobic capacity between children with sickle cell anemia and matched controls

M. Buchowski, B. Saville, Zengqi Lu, 2015, Pediatric blood & cancer.

Impact of proximity to comprehensive sickle cell center on utilization of healthcare services among children with sickle cell disease

P. Arbogast, Winfred C. Wang, M. Griffin, 2008, Pediatric blood & cancer.

Long term effects of therapy among childhood cancer survivors treated in the last two decades

S. Shankar, J. Dean, Duaa AbdelHameid, 2019, Pediatric Hematology Oncology Journal.

Pulmonary hypertension complicating bone marrow transplantation for idiopathic myelofibrosis.

D. Head, J. Choi, T. Dermody, 2004, Journal of pediatric hematology/oncology.

Management of Pneumocystis jiroveci Pneumonia in Children Receiving Chemotherapy

S. Shankar, J. Nania, J. J. Nania, 2007, Paediatric drugs.

Pharmacokinetics of single daily dose gentamicin in children with cancer.

B. Lange, R. Jew, L. Bell, 1996, Journal of pediatric hematology/oncology.

Safety and efficacy of a continuous infusion, patient‐controlled antiemetic pump for children receiving emetogenic chemotherapy

J. Whitlock, T. Koyama, J. Kuttesch, 2007, Pediatric Blood & Cancer.

Growth patterns in children with sickle cell anemia during puberty

M. Buchowski, M. Rhodes, S. Acra, 2009, Pediatric blood & cancer.

Energy Expenditure, Inflammation, and Oxidative Stress in Steady-State Adolescents With Sickle Cell Anemia

J. Morrow, Kong Y. Chen, M. Buchowski, 2007, Pediatric Research.

Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.

P. Nathan, J. Steinberger, M. Hudson, 2015, The Lancet. Oncology.

Use of Air Displacement Plethysmography in the Determination of Percentage of Fat Mass in African American Children

Kong Y. Chen, M. Buchowski, A. Buchholz, 2004, Pediatric Research.

Health care utilization by adult Hispanic long‐term survivors of hematopoietic stem cell transplantation

S. Bhatia, S. Forman, S. Shankar, 2008, Cancer.

Pneumocystis pneumonia in children receiving chemotherapy

S. Shankar, Pinki K. Prasad, Joseph J. Nania, 2008, Pediatric blood & cancer.

Utility of FDG-PET/CT in Follow-Up of Children Treated for Hodgkin and Non-Hodgkin Lymphoma

W. Martin, D. Delbeke, J. Whitlock, 2006, Journal of pediatric hematology/oncology.

Growth in Children Undergoing Bone Marrow Transplantation After Busulfan and Cyclophosphamide Conditioning

N. Bunin, S. Shankar, T. Moshang, 1996, Journal of pediatric hematology/oncology.

Genome sequencing analysis of blood cells identifies germline haplotypes strongly associated with drug resistance in osteosarcoma patients

R. Iyer, T. Vilboux, E. Yang, 2019, BMC Cancer.

Defects in postabsorptive plasma homeostasis of fatty acids in sickle cell disease.

P. Flakoll, N. Abumrad, M. Buchowski, 2007, JPEN. Journal of parenteral and enteral nutrition.

In utero exposure to female hormones and germ cell tumors in children

X. Shu, H. Cai, L. Robison, 2006, Cancer.

INTESTINAL COMPLICATIONS IN CHILDREN UNDERGOING CHEMOTHERAPY FOR MEDIASTINAL NON-HODGKIN LYMPHOMA

S. Shankar, J. Pietsch, S. Hata, 2004, Pediatric Hematology & Oncology.

A phase 1, open label, dose escalation study of MGD009, a humanized B7-H3 x CD3 DART protein, in combination with MGA012, an anti-PD-1 antibody, in patients with relapsed or refractory B7-H3-expressing tumors.

P. Moore, J. Wigginton, J. Strauss, 2018 .

A phase 1, open-label, dose escalation study of enoblituzumab (MGA271) in pediatric patients with B7-H3-expressing relapsed or refractory solid tumors.

J. Maris, P. Moore, J. Wigginton, 2017 .

Marked eosinophilia masking B lymphoblastic leukemia

G. Wertheim, R. Aplenc, S. Shankar, 2016, American journal of hematology.

Neurologic complications of treatment of childhood acute immune thrombocytopenic purpura with intravenously administered immunoglobulin G.

A. Cohen, A. Kattamis, S. Shankar, 1997, The Journal of pediatrics.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Amanda R. Campbell, F. Lund-Johansen, Yair Benita, 2016 .

545 A phase 2 study of retifanlimab in patients with advanced or metastatic merkel cell carcinoma (MCC) (POD1UM-201)

M. Burgess, M. Guida, P. Rutkowski, 2021, Journal for ImmunoTherapy of Cancer.